Expanded Access (Compassionate Use) Treatment Protocol Rindopepimut (CDX-110)

Trial Profile

Expanded Access (Compassionate Use) Treatment Protocol Rindopepimut (CDX-110)

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 23 Oct 2017

At a glance

  • Drugs Antineoplastics (Primary) ; Bevacizumab (Primary) ; Rindopepimut (Primary) ; Temozolomide (Primary)
  • Indications Glioblastoma
  • Focus Expanded access; Therapeutic Use
  • Most Recent Events

    • 16 Oct 2017 Status changed from recruiting to completed.
    • 02 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top